Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Wolf, P; Weger, W; Legat, F; Painsi, C; Saxinger, W; Müllegger, R; Sator, P; Ratzinger, G; Selhofer, S; Richter, L; Salmhofer, W; Lange-Asschenfeldt, B; Trautinger, F; Mlynek, A; Strohal, R; Augustin, M; Quehenberger, F.
Quality of life and treatment goals in psoriasis from the patient perspective: results of an Austrian cross-sectional survey.
J Dtsch Dermatol Ges. 2018; 16(8): 981-990.
Web of Science PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Legat Franz
Painsi Clemens
Quehenberger Franz
Salmhofer Wolfgang
Weger Wolfgang
Wolf Peter
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
Patients with psoriasis experience impairment in quality of life. Thus, high-quality dermatological care is of particular importance. We performed a nationwide cross-sectional survey in Austria (BQSAustria Psoriasis 2014/2015) with a special focus on quality of life and satisfaction with treatment among psoriasis patients predominantly treated at tertiary care centers. Overall, 70.2 % of 1,184 patients reported impaired quality of life (DLQI 2-5: 29.4 %; 6-10: 19.3 %; 11-15: 11.5 %; 16-20: 5.2 % and > 20: 4.9 %) despite treatment over the preceding four weeks (topical treatment in 88.2 % of cases and/or systemic treatment in 38.7 %). On average, none of the 25 defined subjective treatment goals was achieved to a sufficient degree. In particular, 82.2 % of patients continued to have pruritus despite treatment, which was highly significantly associated with a poor general health status over the preceding week (Spearman's rank correlation; p  =  1.1e-45), the extent of body surface area (p  =  3.2e-11) and scalp area (p  =  3.2e-11) affected, as well as pain (p  =  2.3e-22). Treatment with a biologic was significantly correlated with higher patient satisfaction (Wilcoxon-Test, p  =  2.0e-16). Despite dermatological care, the majority of Austrian psoriasis patients continues to experience impaired quality of life; there is potential for improvement in the achievement of treatment goals. © 2018 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.

© Meduni Graz Impressum